ストックスクリーナーアプリを入手
2.32
1.75%
0.04
アフターアワーズ：
2.31
-0.010
-0.43%
前日終値:
$2.28
開ける：
$2.2
24時間の取引高:
626.16K
Relative Volume:
0.72
時価総額：
$112.07M
収益：
-
当期純損益:
$-97.22M
株価収益率:
-1.6812
EPS:
-1.38
ネットキャッシュフロー:
$-82.44M
1週間 パフォーマンス:
+7.41%
1か月 パフォーマンス:
+19.59%
6か月 パフォーマンス:
+2.20%
1年 パフォーマンス:
-3.33%
1日の値動き範囲:
$2.19
$2.33
1週間の範囲:
$2.14
$2.4899
52週間の値動き範囲:
$1.15
$4.98
Cassava Sciences Inc Stock (SAVA) Company Profile
名前
Cassava Sciences Inc
セクター
電話
512-501-2444
住所
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Compare SAVA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.32 | 110.14M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
| 2021-04-27 | 開始されました | B. Riley Securities | Buy |
| 2021-02-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-09-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-01-10 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Cassava Sciences Inc (SAVA) 最新ニュース
SAVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cassava Sciences (NASDAQ:SAVA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Cassava Sciences Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Dow Update: Can Cassava Sciences Inc beat the S P 500July 2025 PreEarnings & Free Long-Term Investment Growth Plans - baoquankhu1.vn
MSN Money - MSN
Cassava Sciences says DOJ has closed probe into allegations around its Alzheimer’s program - MSN
Cassava Sciences says US DOJ has closed investigation into company - Classic Rock 103.5 WIMZ
DOJ closes inquiry into Cassava Sciences over research misconduct By Investing.com - Investing.com Canada
JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B - Stocktwits
Cassava Sciences Says DOJ Has Closed Probe Into Allegations Around Its Alzheimer’s Program - Asianet Newsable
Cassava Sciences stock rises after DOJ closes investigation By Investing.com - Investing.com Canada
Cassava Sciences DOJ Inquiry Closed, Legal Overhang Eased - TipRanks
Cassava says DoJ closed probe into research misconduct (SAVA) - Seeking Alpha
DOJ closes inquiry into Cassava Sciences over research misconduct - Investing.com
Cassava Sciences says DOJ closes inquiry after prior indictment dismissal - TradingView
Cassava Announces Closure of U.S. Department of Justice Investigation - The Manila Times
Cassava Sciences, Inc. Announces Closure of U.S. Department of Justice Investigation - marketscreener.com
Justice Dept closes Cassava research misconduct inquiry, ending federal probes - Stock Titan
DOJ closes probe into Cassava Sciences over Simufilam | Tap to know more | Inshorts - Inshorts
How sensitive is Cassava Sciences Inc. to inflation2025 Macro Impact & Growth Focused Entry Point Reports - mfd.ru
SAVA Should I Buy - Intellectia AI
Aug Outlook: Can Cassava Sciences Inc. (PX91) stock sustain revenue momentum2025 Market Outlook & AI Driven Price Predictions - mfd.ru
Fed Watch: What are Cassava Sciences Incs technical support levelsJuly 2025 Retail & High Win Rate Trade Tips - baoquankhu1.vn
Can Cassava Sciences Inc. Equity Warrant maintain its current growth rateJuly 2025 Opening Moves & Weekly Breakout Watchlists - mfd.ru
Cassava Sciences And 2 Other Promising Penny Stocks - Yahoo Finance
Cassava Sciences Target of Unusually High Options Trading (NASDAQ:SAVA) - MarketBeat
Is Cassava Sciences Inc. Equity Warrant stock a smart buy before Fed meetingJuly 2025 Movers & AI Powered Trade Plan Recommendations - mfd.ru
Cassava Sciences (NASDAQ:SAVA) Upgraded to Hold at Wall Street Zen - MarketBeat
Setup Watch: Is Cassava Sciences Inc Equity Warrant subject to activist investor interestJuly 2025 Gainers & Smart Swing Trading Alerts - baoquankhu1.vn
Is Cassava Sciences Inc. stock influenced by commodity prices2025 Bull vs Bear & High Accuracy Investment Signals - mfd.ru
What are Cassava Sciences Inc.’s technical support levelsJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - mfd.ru
Stock Analysis: Does Cassava Sciences Inc Equity Warrant have pricing powerRecession Risk & Smart Money Movement Alerts - baoquankhu1.vn
Setup Watch: What is Cassava Sciences Inc Equity Warrants book value per shareGold Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
Cassava Sciences (NASDAQ:SAVA) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Retail Surge: What are the future prospects of Cassava Sciences Inc Equity Warrant2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
The Truth About Cassava Sciences: Wall Street’s Wildcard Stock Everyone Keeps Arguing About - AD HOC NEWS
Aug Retail: What is Cassava Sciences Inc Equity Warrants book value per shareDollar Strength & Verified Trade Idea Suggestions - baoquankhu1.vn
Energy Moves: Is Cassava Sciences Inc backed by strong institutional buyingDay Trade & Daily Stock Trend Reports - baoquankhu1.vn
Cassava Sciences publishes phase 3 Alzheimer’s trial results in JPAD By Investing.com - Investing.com Nigeria
RSI Check: How Cassava Sciences Inc stock trades during market volatilityEarnings Performance Report & Smart Swing Trading Alerts - Bộ Nội Vụ
Cassava Sciences publishes phase 3 Alzheimer’s trial results in JPAD - Investing.com
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease - Yahoo Finance
Will Cassava Sciences Inc. stock benefit from sector rotationMarket Trend Summary & Smart Money Movement Alerts - ulpravda.ru
What valuation multiples suggest for Cassava Sciences Inc. Equity Warrant stockJuly 2025 Summary & AI Based Buy and Sell Signals - ulpravda.ru
Why Cassava Sciences Inc. Equity Warrant stock remains a top recommendationJuly 2025 Weekly Recap & High Return Trade Guides - ulpravda.ru
How Cassava Sciences Inc. (PX91) stock reacts to weak economyMarket Volume Report & Verified Momentum Watchlists - Улправда
Why Cassava Sciences Inc. (PX91) stock is a must watch tickerWeekly Trend Summary & Trade Opportunity Analysis Reports - Улправда
Signal Recap: Why Cassava Sciences Inc. Equity Warrant stock appeals to analystsJuly 2025 Trends & Growth Focused Stock Pick Reports - Улправда
Trend Review: What valuation ratios show for Cassava Sciences Inc. (PX91) stockWeekly Profit Report & Safe Entry Momentum Stock Tips - Улправда
Cassava Sciences Inc (SAVA) 財務データ
収益
当期純利益
現金流量
EPS
2.90%
2.73%
大文字化:
|
ボリューム (24 時間):